Johannes Pöhlmann (J Pöhlmann)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Patient related outcome measures

Journal of medical economics

Diabetes therapy : research, treatment and education of diabetes and related disorders

Journal of diabetes science and technology

Universitätsmedizin Mainz

London School of Hygiene and Tropical Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitätsmedizin Mainz Aug 01 2020

Germany

Doctoral Candidate :: Präventive Kardiologie und Medizinische Prävention

Zürcher Hochschule für Angewandte Wissenschaften Mar 01 2019 - Jul 31 2020

Switzerland

Wissenschaftlicher Mitarbeiter :: School of Management and Law

Ossian Health Economics and Communications GmbH Sep 01 2016 - Feb 28 2019

Switzerland

Health Economist

Education History

London School of Hygiene and Tropical Medicine Sep 01 2014 - Jul 31 2015

United Kingdom

MSC

Publications

Dusica Hadzi Boskovic, Jayne Smith-Palmer, Johannes Pöhlmann, Richard F Pollock, Steve Hwang, David Bruhn
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia. Patient related outcome measures 15 (2024)
Dusica Hadzi Boskovic, Jayne Smith-Palmer, Johannes Pöhlmann, Richard F Pollock, Steve Hwang, David Bruhn
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia. Patient related outcome measures 15 (2024)
Kristin Grabe-Heyne, Christof Henne, Isaac Odeyemi, Johannes Pöhlmann, Waqas Ahmed, Richard F Pollock
Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK. Journal of medical economics 26 (1) (2023)
Shanlian Hu, De-Pei Wu, Jing Wu, Yabing Zhang, Mette Bøgelund, Johannes Pöhlmann, Richard F Pollock
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China. Patient related outcome measures 14 (2023)
Kristin Grabe-Heyne, Christof Henne, Isaac Odeyemi, Johannes Pöhlmann, Waqas Ahmed, Richard F Pollock
Evaluating the cost-utility of intravesical bacillus calmette-guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK. Journal of medical economics (2023)
Johannes Pöhlmann, Klas Bergenheim, Juan Jose Garcia Sanchez, Naveen Rao, Andrew H Briggs, Richard F Pollock
Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (4) (2022)
Shanlian Hu, Limin Liu, Richard F Pollock, Johannes Pöhlmann, Depei Wu, Yabing Zhang
Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose. Journal of medical economics 25 (1) (2022)
Johannes Pöhlmann, Kirsi Norrbacka, K S Boye, W J Valentine, H Sapin
Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy. The European journal of health economics : HEPAC : health economics in prevention and care 21 (8) (2020)
Johannes Pöhlmann, Monika Russel-Szymczyk, Pavel Holík, Karel Rychna, Barnaby Hunt
Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (2) (2019)
Johannes Pöhlmann, Beth D Mitchell, Sanjay Bajpai, Beatrice Osumili, William J Valentine
Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis. Journal of diabetes science and technology 13 (5) (2019)
Marlene Gyldmark, Kristian Lampe, Jörg Ruof, Johannes Pöhlmann, Ansgar Hebborn, Finn Børlum Kristensen
IS THE EUNETHTA HTA CORE MODEL® FIT FOR PURPOSE? EVALUATION FROM AN INDUSTRY PERSPECTIVE. International journal of technology assessment in health care 34 (5) (2018)

Johannes Pöhlmann.css-eqlu8i{font-size:small;padding-left:4px;} (J Pöhlmann)

Publication Activity (10 Years)

Top Topics

Top Venues

Johannes Pöhlmann (J Pöhlmann)